281 related articles for article (PubMed ID: 27470143)
1. Bacterial production and structure-functional validation of a recombinant antigen-binding fragment (Fab) of an anti-cancer therapeutic antibody targeting epidermal growth factor receptor.
Kim JH; Sim DW; Park D; Jung TG; Lee S; Oh T; Ha JR; Seok SH; Seo MD; Kang HC; Kim YP; Won HS
Appl Microbiol Biotechnol; 2016 Dec; 100(24):10521-10529. PubMed ID: 27470143
[TBL] [Abstract][Full Text] [Related]
2. A collagen-binding EGFR antibody fragment targeting tumors with a collagen-rich extracellular matrix.
Liang H; Li X; Wang B; Chen B; Zhao Y; Sun J; Zhuang Y; Shi J; Shen H; Zhang Z; Dai J
Sci Rep; 2016 Feb; 6():18205. PubMed ID: 26883295
[TBL] [Abstract][Full Text] [Related]
3. Isolation of a human anti-epidermal growth factor receptor Fab antibody, EG-19-11, with subnanomolar affinity from naïve immunoglobulin repertoires using a hierarchical antibody library system.
Hur BU; Yoon JB; Liu LK; Cha SH
Immunol Lett; 2010 Nov; 134(1):55-61. PubMed ID: 20797408
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab.
Li S; Schmitz KR; Jeffrey PD; Wiltzius JJ; Kussie P; Ferguson KM
Cancer Cell; 2005 Apr; 7(4):301-11. PubMed ID: 15837620
[TBL] [Abstract][Full Text] [Related]
5. Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation.
Talavera A; Friemann R; Gómez-Puerta S; Martinez-Fleites C; Garrido G; Rabasa A; López-Requena A; Pupo A; Johansen RF; Sánchez O; Krengel U; Moreno E
Cancer Res; 2009 Jul; 69(14):5851-9. PubMed ID: 19584289
[TBL] [Abstract][Full Text] [Related]
6. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
[TBL] [Abstract][Full Text] [Related]
7. 'Zipbody' leucine zipper-fused Fab in E. coli in vitro and in vivo expression systems.
Ojima-Kato T; Fukui K; Yamamoto H; Hashimura D; Miyake S; Hirakawa Y; Yamasaki T; Kojima T; Nakano H
Protein Eng Des Sel; 2016 Apr; 29(4):149-57. PubMed ID: 26902097
[TBL] [Abstract][Full Text] [Related]
8. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
9. Bacterial production and functional characterization of the Fab fragment of the murine IgG1/lambda monoclonal antibody cmHsp70.1, a reagent for tumour diagnostics.
Friedrich L; Stangl S; Hahne H; Küster B; Köhler P; Multhoff G; Skerra A
Protein Eng Des Sel; 2010 Apr; 23(4):161-8. PubMed ID: 20123884
[TBL] [Abstract][Full Text] [Related]
10. Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR).
Akbari B; Farajnia S; Zarghami N; Mahdieh N; Rahmati M; Khosroshahi SA; Rahbarnia L
Protein Expr Purif; 2016 Nov; 127():8-15. PubMed ID: 27298212
[TBL] [Abstract][Full Text] [Related]
11. Biochemical separation of Cetuximab-Fab from papain-digested antibody fragments and radiolabeling with
Chakravarty R; Rohra N; Jadhav S; Sarma HD; Jain R; Chakraborty S
Appl Radiat Isot; 2023 Jun; 196():110795. PubMed ID: 37004293
[TBL] [Abstract][Full Text] [Related]
12. Identification and grafting of a unique peptide-binding site in the Fab framework of monoclonal antibodies.
Donaldson JM; Zer C; Avery KN; Bzymek KP; Horne DA; Williams JC
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17456-61. PubMed ID: 24101516
[TBL] [Abstract][Full Text] [Related]
13. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
[TBL] [Abstract][Full Text] [Related]
14. Expression of actively soluble antigen-binding fragment (Fab) antibody and GFP fused Fab in the cytoplasm of the engineered Escherichia coli.
Krittanai S; Putalun W; Sakamoto S; Tanaka H; Juengwatanatrakul T; Yusakul G
Mol Biol Rep; 2020 Jun; 47(6):4519-4529. PubMed ID: 32394307
[TBL] [Abstract][Full Text] [Related]
15. Efficient secretion of murine Fab fragments by Escherichia coli is determined by the first constant domain of the heavy chain.
Alfthan K; Takkinen K; Sizmann D; Seppälä I; Immonen T; Vanne L; Keränen S; Kaartinen M; Knowles JK; Teeri TT
Gene; 1993 Jun; 128(2):203-9. PubMed ID: 8514187
[TBL] [Abstract][Full Text] [Related]
16. Effective therapeutic approach for head and neck cancer by an engineered minibody targeting the EGFR receptor.
Kim YP; Park D; Kim JJ; Chi WJ; Lee SH; Lee SY; Kim S; Chung JM; Jeon J; Lee BD; Shin JH; Lee YI; Cho H; Lee JM; Kang HC
PLoS One; 2014; 9(12):e113442. PubMed ID: 25438047
[TBL] [Abstract][Full Text] [Related]
17. Cetuximab directly inhibits P-glycoprotein function in vitro independently of EGFR binding.
Chu C; Noël-Hudson MS; Bénard J; Ha-Duong T; Allaoui F; Farinotti R; Bonhomme-Faivre L
Eur J Pharm Sci; 2015 Aug; 76():18-26. PubMed ID: 25930120
[TBL] [Abstract][Full Text] [Related]
18. Structure of the Fab fragment of the anti-murine EGFR antibody 7A7 and exploration of its receptor binding site.
Talavera A; Mackenzie J; Garrido G; Friemann R; López-Requena A; Moreno E; Krengel U
Mol Immunol; 2011 Jul; 48(12-13):1578-85. PubMed ID: 21592580
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment.
Kirley TL; Norman AB
Hum Vaccin Immunother; 2015; 11(2):458-67. PubMed ID: 25692880
[TBL] [Abstract][Full Text] [Related]
20. Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization.
Schmiedel J; Blaukat A; Li S; Knöchel T; Ferguson KM
Cancer Cell; 2008 Apr; 13(4):365-73. PubMed ID: 18394559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
